The global biophotonics market is expected to record a CAGR of 11.3% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 54,320.0 million. By 2033, the valuation is anticipated to reach US$ 1,58,457.0 million. The biophotonics market is expected to grow significantly in the coming years, driven by increasing demand for non-invasive and non-destructive diagnostic tools and advancements in photonics and related technologies.
Biophotonics Market is Expected to Expand Significantly in the Coming Years Due to Several Growth Factors, Including
Advances in photonics and related technologies, such as imaging and sensing, have enabled the development of advanced biophotonics technologies that offer high-resolution and high-speed imaging capabilities, as well as improved sensitivity and specificity in disease diagnosis.
The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes drives the demand for biophotonics-based diagnostic and therapeutic technologies.
Growing investments in research and development activities in biophotonics and related technologies are driving the development of new and advanced biophotonics technologies.
Governments worldwide are supporting the development of biophotonics technologies through funding and regulatory initiatives, which are expected to drive the market's growth.
The ageing population is increasing the demand for healthcare services, including diagnostic and therapeutic procedures, fueling the demand for biophotonics-based technologies.
The growing trend towards personalized medicine drives the demand for biophotonics-based technologies, as they offer high-resolution imaging and molecular analysis capabilities for personalized disease diagnosis and treatment.
| Attributes | Value |
|---|---|
| Biophotonics Value (2022) | US$ 52,538.9 million |
| Biophotonics Market Expected Value (2023) | US$ 54,320.0 million |
| Biophotonics Market Forecast Value (2033) | US$ 1,58,457.0 million |
| Biophotonics Market Expected CAGR (2023 to 2033) | 11.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Addressing these challenges is likely important to ensure the growth and development of the biophotonics market in the coming years. This may require investments in research and development, standardization efforts, regulatory reforms, and education and training programs to increase healthcare professionals' awareness and expertise in biophotonics.
Principal Consultant
Biophotonics technology is applicable across multiple industry sectors, including biotechnology, diagnostics, therapeutics, and agriculture. Optical techniques allow for the non-invasive observation of biological cells while maintaining their integrity.
This involves interactions such as absorption, detection, emission, reflection, radiation, modification, and creation between biological cells or molecules and light. Biophotonics has the potential to revolutionize the way we understand and approach healthcare, offering new avenues for disease detection and treatment.
Biophotonics technology is poised to significantly impact a wide range of fields, including environmental monitoring, food analysis, Raman spectroscopy, endoscopy, dosimetry, and dentistry.
Biophotonics enables the non-invasive observation and analysis of biological cells and tissues, offering new insights and opportunities for disease diagnosis and treatment.
The biophotonics market report provides an overview of this rapidly developing field, highlighting its potential for improving healthcare outcomes through light-based technologies. Biophotonics has the potential to revolutionize various sectors and enable us to cure diseases in more effective ways.
Biophotonics is categorically split into three components: biophotonics end user, biophotonics technology, biophotonics applications, and biophotonics region-wise analysis.
The biophotonics market report includes a detailed analysis of each vertical and sub-vertical, providing insights into the market size and growth potential. The report also segments end-use sectors into medical diagnostics, medical therapeutics, test components, and non-medical end users. The application segment is also divided into see-through imaging, spectro-molecular, light therapy, biosensors, microscopy, and surface imaging. By breaking down the market into these segments, the report offers a comprehensive understanding of the various applications of biophotonics technology and its potential impact across multiple sectors.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The biophotonics market report also provides a comprehensive regional analysis of the industry. The report evaluates the market size and growth potential of biophotonics technology across key regions including North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East and Africa (MEA)
In North America, the biophotonics market is expected to witness significant growth due to the presence of key players in the region and the increasing demand for advanced diagnostic and therapeutic solutions.
In Asia Pacific, the biophotonics market is expected to experience substantial growth due to rising investments in healthcare infrastructure, increasing healthcare expenditure, and a huge patient pool. China is expected to record a CAGR of 12.4% over the forecast period.
The biophotonics market in Europe is a significant player in the global biophotonics industry, driven by the growing ageing population, increasing healthcare expenditure, and demand for improved healthcare services. The region has a well-established healthcare infrastructure and a significant presence of key players in the biophotonics market.
According to the FMI analysis, the medical diagnostics sector is expected to account for a significant share of the biophotonics market in Europe, driven by increasing demand for non-invasive and advanced diagnostic solutions. The microscopy application segment is also expected to witness substantial growth in the region, driven by the increasing use of microscopy techniques in medical research and diagnosis.
In general, the biophotonics market is expected to experience strong growth across all regions, driven by increasing demand for non-invasive and advanced diagnostic and therapeutic solutions, as well as technological advancements in the field of photonics.
Leading companies like Becton Dickinson & Co., Affymetrix Inc., Olympus America, Andor Technology, Hamamatsu Technologies, and Carl Zeiss are employing various strategies to stay ahead in the market. These tactics include partnering with other companies, signing sales contracts, forming strategic alliances, diversifying their offerings, launching innovative products, engaging in mergers and acquisitions, conducting research and development, upgrading their technologies, expanding their product lines, hiring technical experts, forming joint ventures, collaborating with other businesses, and obtaining product approvals. By adopting these measures, these companies aim to gain a competitive edge over their rivals.
Developments in the Market
With this advanced technology, physicians can perform minimally invasive procedures to biopsy mediastinal and hilar lymph nodes with greater precision, enhancing their ability to diagnose and stage lung cancer more effectively.
On April 30, 2021, Olympus launched a new line of premium endoscopes specifically designed for advanced diagnostic and therapeutic procedures. The H-SteriScope portfolio is the result of a collaborative effort between Olympus, Veran Medical Technologies, Inc., and Hunan Vathin Medical Instrument Co., Ltd.
This collaboration has enabled Olympus to expand its offerings and deliver advanced medical technology to its customers. The H-SteriScope portfolio is a significant addition to the company's product line and reflects its commitment to developing innovative solutions that improve patient outcomes.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Growth Rate (2023 to 2033) | 11.3% CAGR |
| Market Analysis | US$ million for Market Value |
| Market Value for 2022 | US$ 52,538.9 million |
| Key Regions Covered | North America, Latin America, Europe, South Asia and Pacific, East Asia, Middle East & Africa |
| Key Segments Covered | Product Type, Material Type, Pressure Intake, Application, and Region |
| Key Companies Profiled | Becton Dickinson & Co., Affymetrix Inc., Olympus America, Andor Technology, Hamamatsu Technologies, and Carl Zeiss |
| Report Coverage | Market Forecast, Competitive Landscape, Region-wise and Category-wise Insights, Key Trends, Key Challenges |
| Customization & Pricing | Available upon Request |
The CAGR for the market is 11.3% until 2033.
From 2018 to 2022, the market expanded at a 3.4% CAGR.
China is expected to record a 12.4% CAGR until 2033.
Olympus America, Andor Technology, and Becton Dickinson & Co. are key players.
Chronic diseases and advanced treatments are expected to drive the market.
1. Executive Summary | Biophotonics Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 5.3.1. See-Through Imaging 5.3.2. Microscopy 5.3.3. Spectro Molecular 5.3.4. Inside Imaging 5.3.5. Analytics Sensing 5.3.6. Light Therapy 5.3.7. Surface Imaging 5.3.8. Biosensors 5.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Tests and Components 6.3.2. Medical Therapeutics 6.3.3. Medical Diagnostics 6.3.4. Non-Medical Application 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. South Asia 7.3.5. East Asia 7.3.6. Oceania 7.3.7. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Application 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Application 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Application 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Application 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Application 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Application 10.3.3. By End User 10.4. Key Takeaways 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. India 11.2.1.2. Malaysia 11.2.1.3. Singapore 11.2.1.4. Thailand 11.2.1.5. Rest of South Asia 11.2.2. By Application 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Application 11.3.3. By End User 11.4. Key Takeaways 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Application 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Application 12.3.3. By End User 12.4. Key Takeaways 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Application 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Application 13.3.3. By End User 13.4. Key Takeaways 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Application 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Application 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Application 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Application 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Application 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Application 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Application 15.5.2.2. By End User 15.6. United kingdom 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Application 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Application 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Application 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Application 15.9.2.2. By End User 15.10. India 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Application 15.10.2.2. By End User 15.11. Malaysia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Application 15.11.2.2. By End User 15.12. Singapore 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Application 15.12.2.2. By End User 15.13. Thailand 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Application 15.13.2.2. By End User 15.14. China 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Application 15.14.2.2. By End User 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Application 15.15.2.2. By End User 15.16. South Korea 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Application 15.16.2.2. By End User 15.17. Australia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Application 15.17.2.2. By End User 15.18. New Zealand 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Application 15.18.2.2. By End User 15.19. GCC Countries 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Application 15.19.2.2. By End User 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Application 15.20.2.2. By End User 15.21. Israel 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Application 15.21.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Application 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Becton, Dickinson & Co. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Affymetrix Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Carl Zeiss 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Olympus America 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Andor Technology 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Hamamatsu Photonics 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Thermofisher Scientific 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. PerkinElmer 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Zenalux Biomedical Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. NU Skin Enterprises 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Chemicals & Materials Insights
View Reports
Biophotonics Market
